1984
DOI: 10.1021/ja00329a055
|View full text |Cite
|
Sign up to set email alerts
|

Modification of an enzyme carboxylate residue in the inhibition of 3-oxo-.DELTA.5-steroid isomerase by (3S)-spiro[5.alpha.-androstane-3,2'-oxirane]-17.beta.-ol. Implications for the mechanism of action

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

4
30
0

Year Published

1984
1984
1999
1999

Publication Types

Select...
8
1

Relationship

2
7

Authors

Journals

citations
Cited by 27 publications
(34 citation statements)
references
References 0 publications
4
30
0
Order By: Relevance
“…In order to confirm that equilenin binds at the active site of KSI, the active-site-directed irreversible inhibitor (35)spiro[5a-androstane-3,2'-oxiran]-17-one (Pollack et al, 1986) was added to a solution of equilenin and KSI at both pH 7.1 and pH 3.9. This oxirane is one of a variety of 3/3-oxiranes that bind covalently and stoichiometrically at the active site of KSI (Bevins et al, 1984;Pollack et al, 1986;Bounds & Pollack, 1987). Upon addition of the inhibitor to a solution of equilenin and KSI at both pH 7.0 (28 µ oxirane) and at pH 3.8 (69 µ oxirane), the characteristic excitation spectrum of free equilenin slowly increases, as the equilenin is displaced from KSI by the oxirane (Figure 3).…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…In order to confirm that equilenin binds at the active site of KSI, the active-site-directed irreversible inhibitor (35)spiro[5a-androstane-3,2'-oxiran]-17-one (Pollack et al, 1986) was added to a solution of equilenin and KSI at both pH 7.1 and pH 3.9. This oxirane is one of a variety of 3/3-oxiranes that bind covalently and stoichiometrically at the active site of KSI (Bevins et al, 1984;Pollack et al, 1986;Bounds & Pollack, 1987). Upon addition of the inhibitor to a solution of equilenin and KSI at both pH 7.0 (28 µ oxirane) and at pH 3.8 (69 µ oxirane), the characteristic excitation spectrum of free equilenin slowly increases, as the equilenin is displaced from KSI by the oxirane (Figure 3).…”
Section: Resultsmentioning
confidence: 99%
“…Three possibilities have been considered (Scheme II): (a) proton transfer to the carbonyl preceding loss of the 4/3-proton, with the formation of an oxocarbonium ion intermediate (Malhotra & Ringold, 1965;Bevins et al, 1984;Kuliopulos et al, 1989); (b) concerted proton transfer from Tyr-14 to the carbonyl and from C-4/S to Asp-38 (Xue et al, 1990; Kuliopulos et al, 1990Kuliopulos et al, , 1991; and (c) deprotonation at C-4 by Asp-38 with only hydrogen bonding from Tyr-14 in the 0006-2960/92/0431-1521 $03.00/0 transition state, producing an intermediate carbanion (Pollack et al, 1989a;Zeng & Pollack, 1991).…”
mentioning
confidence: 99%
“…Binding should be substantially tighter in the 1-2% methanol solutions used in this work (Falcoz-Kelly et al, 1968). 17/3-oxiranes (Bevins et al, 1984;.…”
Section: Discussionmentioning
confidence: 99%
“…The profound decrease of kat by a factor of 105 6 upon mutation of Asp-38 to asparagine (Table I), together with the inhibitory effects of affinity labeling (Martyr & Benisek, 1973Benisek et al, 1980Benisek et al, , 1984Hearne & Benisek, 1985;Pollack et al, 1979Pollack et al, , 1986Kayser et al, 1983;Bevins et al, 1980Bevins et al, , 1984Bounds & Pollack, 1987), and chemical modification of this residue (Benisek et al, 1980) indicate that Asp-38 is the proton acceptor in the isomerase reaction. The inability of OH" to replace Asp-38 is also consistent with the low solvent accessibility of the active site.…”
Section: Wavelength Nmmentioning
confidence: 99%